nytimes.com

The Liftoff Scenario That Terrifies A.I. Doomsayers

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
The Guardian

I worked at Google DeepMind. You should listen to the warnings about AI

We must stop companies from allowing AI to self-improve into an uncontrollable level of intelligence Major AI lab CEOs advocated for slowing the pace of AI development this weekend. They are right to ...
scmp.com

The US and China are racing to build ‘self-improving AI’. Here’s what’s at stake

The US-China race for artificial intelligence dominance has entered a new phase: using AI to build better AI. Leading AI companies in the United States and China are increasingly focused on deploying ...
The Guardian

‘We must slow the pace’: CEO of Anthropic calls for an AI slowdown

In a social media post, Dario Amodei proposed a plan including third-party evaluations of AI systems The CEO of the artificial intelligence company Anthropic issued a new appeal on Saturday for the AI ...
MIT Technology Review

AI’s recursive self-improvement might not come so quickly after all

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Time

Inside the Race to Make AI Build Itself

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
TechCrunch

Jeff Dean and other top AI researchers are leaving Google to launch their own startup

Jeff Dean, one of the longest-serving and most influential executives at Google, is stepping down from the search giant to launch his own AI startup. Coming with him as co-founders are several other ...
GEN

Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Bloomberg

Roche Advances AI-Derived Drug Target With Partner Recursion

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.
TechCrunch

Recursive Superintelligence signs $410M compute deal with Amazon

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
The Conversation

Is recursive self‑improvement the dawning of AI superintelligence?

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. “We are not there yet, and recursive self-improvement is not ...